Nuclear translocation of cleaved LyGDI dissociated from Rho and Rac during Trp53-dependent ionizing radiation-induced apoptosis of thymus cells in vitro

Radiation Research

Volumn 162, Issue 3, 2004, Pages 287-295

  Zhou, Xinwen ^a,b   Suto, Shiho ^a   Ota, Takahide ^c   Tatsuka, Masaaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b SOOCHOW UNIVERSITY   (China)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; BENZYLOXYCARBONYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE INHIBITOR; LYGDI PROTEIN; RAC PROTEIN; RAC1 PROTEIN; REGULATOR PROTEIN; RHO FACTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRYPTOPHAN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME REGULATION; FRACTIONATION; HEMATOPOIETIC CELL; IMMUNOFLUORESCENCE; IONIZING RADIATION; IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; THYMOCYTE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; CELL LINE, TUMOR; CELL NUCLEUS; DOSE-RESPONSE RELATIONSHIP, RADIATION; LYMPHOMA; MICE; PROTEINS; RAC GTP-BINDING PROTEINS; RADIATION DOSAGE; RADIATION, IONIZING; RHO GTP-BINDING PROTEINS; THYMUS NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 4644250838     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3220     Document Type: Article

References (38)

1. Y. Maruyama and J. M. Feola, Relative radiosensitivities of the thymus, spleen, and lymphohemopoietic systems. Adv. Radiat. Biol. 12, 1-82 (1987).
2. T. Yamada and H. Ohyama, Radiation-induced interphase death of rat thymocytes is internally programmed (apoptosis). Int. J. Radiat. Biol. 53, 65-75 (1988).
3. T. Yamada and H. Ohyama, Characteristics of radiation-induced apoptosis in thymocytes. In Radiation Research 1895-1995, Vol. 2 (U. Hagen, D. Harder, H. Jung and C. Streffer, Eds.), pp. 645-648. Universitätsdruckerei H. Stürtz, AG, Würzburg, Germany, 1996.
4. H. Kawai, Y. Kitamura, O. Nikaido, M. Tatsuka, H. Hama-Inaba, M. Muto, H. Ohyama and F. Suzuki, Isolation and characterization of apoptosis-resistant mutants from a radiosensitive mouse lymphoma cell line. Radiat. Res. 149, 41-51 (1998).
5. H. Kawai, Y. Yamada, M. Tatsuka, O. Niwa, K. Yamamoto and F. Suzuki, Down-regulation of nuclear factor κB is required for p53-dependent apoptosis in X-ray-irradiated mouse lymphoma cells and thymocytes. Cancer Res. 59, 6038-6041 (1999).
6. E. J. Fuchs, K. A. McKenna and A. Bedi, p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta. Cancer Res. 57, 2550-2554 (1997).
7. Y. Yu and J. B. Little, p53 is involved in but not required for ionizing radiation-induced caspase-3 activation and apoptosis in human lymphoblast cell lines. Cancer Res. 58, 4277-4281 (1998).
8. Q. L. Zhao, T. Kondo, A. Noda and Y. Fujiwara, Mitochondrial and intracellular free-calcium regulation of radiation-induced apoptosis in human leukemic cells. Int. J. Radiat. Biol. 75, 493-504 (1999).
9. W. C. Earnshaw, L. M. Martins and S. H. Kaufmann, Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68, 383-424 (1999).
10. B. Olofsson, Rho guanine dissociation inhibitors: Pivotal molecules in cellular signaling. Cell Signal. 11, 545-554 (1999).
11. S. Na, T. H. Chuang, A. Cunningham, T. G. Turi, J. H. Hanke, G. M. Bokoch and D. E. Danley, D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis. J. Biol. Chem. 271, 11209-11213 (1996).
12. D. E. Danley, T. H. Chuang and G. M. Bokoch, Defective Rho GTPase regulation by IL-1 beta-converting enzyme-mediated cleavage of D4 GDP dissociation inhibitor. J. Immunol. 157, 500-503 (1996).
13. J. Xiang, D. T. Chao and S. J. Korsmeyer, BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93, 14559-14563 (1996).
14. A. Rickers, E. Brockstedt, M. Y. Mapara, A. Otto, B. Dorken and K. Bommert, Inhibition of CPP32 blocks surface IgM-mediated apoptosis and D4-GDI cleavage in human BL60 Burkitt lymphoma cells. Eur. J. Immunol. 28, 296-304 (1998).
15. F. Essmann, T. Wieder, A. Otto, E. C. Muller, B. Dorken and P. T. Daniel, GDP dissociation inhibitor D4-GDI (Rho-GDI 2), but not the homologous Rho-GDI 1, is cleaved by caspase-3 during drug-induced apoptosis. Biochem. J. 346, 777-783 (2000).
16. M. H. Pan, W. L. Chang, S. Y. Lin-Shiau, C. T. Ho and J. K. Lin, Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. J. Agric. Food Chem. 49, 1464-1474 (2001).
17. K. B. Kwon, E. K. Park, D. G. Ryu and B. H. Park, D4-GDI is cleaved by caspase-3 during daunorubicin-induced apoptosis in HL-60 cells. Exp. Mol. Med. 34, 32-37 (2002).
18. R. J. Krieser and A. Eastman, Cleavage and nuclear translocation of the caspase 3 substrate Rho GDP-dissociation inhibitor, D4-GDI, during apoptosis. Cell Death Differ. 6, 412-419 (1999).
19. B. Thiede, F. Siejak, C. Dimmler and T. Rudel, Prediction of translocation and cleavage of heterogeneous ribonuclear proteins and Rho guanine nucleotide dissociation inhibitor 2 during apoptosis by subcellular proteome analysis. Proteomics 2, 996-1006 (2002).
20. K. Hayashi, S. Yonemura, T. Matsui and S. Tsukita, Immunofluorescence detection of ezrin/radixin/moesin (ERM) proteins with their carboxyl-terminal threonine phosphorylated in cultured cells and tissues. J. Cell Sci. 112, 1149-1158 (1999).
21. X. Liu, H. Zou, C. Slaughter and X. Wang, DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89, 175-184 (1997).
22. M. Enari, H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu and S. Nagata, A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43-50 (1998).
23. H. Sakahira, M. Enari and S. Nagata, Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391, 96-99 (1998).
24. J. M. Lelias, C. N. Adra, G. M. Wulf, J. C. Guillemot, M. Khagad, D. Caput and B. Lim, cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP-binding proteins. Proc. Natl. Acad. Sci. USA 90, 1479-1483 (1993).
25. P. Scherle, T. Behrens and L. M. Staudt, Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. Proc. Natl. Acad. Sci. USA 90, 7568-7572 (1993).
26. H. Leffers, M. S. Nielsen, A. H. Andersen, B. Honore, P. Madsen, J. Vandekerckhove and J. E. Celis, Identification of two human Rho GDP dissociation inhibitor proteins whose overexpression leads to disruption of the actin cytoskeleton. Exp. Cell Res. 209, 165-174 (1993).
27. Y. Q. Gosser, T. K. Nomanbhoy, B. Aghazadeh, D. Manor, C. Combs, R. A. Cerione and M. K. Rosen, C-terminal binding domain of Rho GDP-dissociation inhibitor directs N-terminal inhibitory peptide to GTPases. Nature 387, 814-819 (1997).
28. N. H. Keep, M. Barnes, I. Barsukov, R. Badii, L. Y. Lian, A. W. Segal, P. C. Moody and G. C. Roberts, A modulator of rho family G proteins, rhoGDI, binds these G proteins via an immunoglobulin-like domain and a flexible N-terminal arm. Structure 5, 623-633 (1997).
29. K. Scheffzek, I. Stephan, O. N. Jensen, D. Illenberger and P. Gierschik, The Rac-RhoGDI complex and the structural basis for the regulation of Rho proteins by RhoGDI. Nat. Struct. Biol. 7, 122-126 (2000).
30. A. P. Golovanov, T. H. Chuang, C. DerMardirossian, I. Barsukov, D. Hawkins, R. Badii, G. M. Bokoch, L. Y. Lian and G. C. Roberts, Structure-activity relationships in flexible protein domains: Regulation of rho GTPases by RhoGDI and D4 GDI. J. Mol. Biol. 305, 121-135 (2001).
31. F. Rivero, D. Illenberger, B. P. Somesh, H. Dislich, N. Adam and A. K. Meyer, Defects in cytokinesis, actin reorganization and the contractile vacuole in cells deficient in RhoGDI. EMBO J. 21, 4539-4549 (2002).
32. K. Robbe, A. Otto-Bruc, P. Chardin and B. Antonny, Dissociation of GDP dissociation inhibitor and membrane translocation are required for efficient activation of Rac by the Db1 homology-pleckstrin homology region of Tiam. J. Biol. Chem. 278, 4756-4762 (2003).
33. T. Ota, M. Maeda, S. Suto and M. Tatsuka, LyGDI functions in cancer metastasis by anchoring Rho proteins to the cell membrane. Mol. Carcinog. 39, 206-220 (2004).
34. T. Fernandes-Alnemri, R. C. Armstrong, J. Krebs, S. M. Srinivasula, L. Wang, F. Bullrich, L. C. Fritz, J. A. Trapani, K. J. Tomaselli and E. S. Alnemri, In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA 93, 7464-7469 (1996).
35. H. Zou, Y. Li, X. Liu and X. Wang, An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274, 11549-11556 (1999).
36. Y. Hu, M. A. Benedict, L. Ding and G. Nunez, Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J. 18, 3586-3595 (1999).
37. S. Ueda, H. Masutani, H. Nakamura, T. Tanaka, M. Ueno and J. Yodoi, Redox control of cell death. Antioxid. Redox Signal 4, 405-414 (2002).
38. H. Kawai, T. Ota, F. Suzuki and M. Tatsuka, Molecular cloning of mouse thioredoxin reductases. Gene 242, 321-330 (2000).